← Back to Search

Group Interventions for Breast Cancer Survivors

N/A

Waitlist Available

Led By Wendy Lichtenthal, PhD

Research Sponsored by Memorial Sloan Kettering Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 or older

History of non-metastatic breast cancer (DCIS or Stage I, II, or III) as recorded in the medical record at MSKCC by self-report, or by outside correspondence, including a study checklist signed by a physician for patients outside of MSKCC

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is comparing the benefits of two types of groups for breast cancer survivors: a Meaning-Centered Group and a Discussion Group.

Who is the study for?

This trial is for breast cancer survivors who have completed treatment, are over 18 years old, and feel distressed related to their cancer or survivorship. They must be stable on any mood-related medications and have access to a phone and internet. Those with metastatic disease or significant psychiatric issues that prevent informed consent are excluded.Check my eligibility

What is being tested?

The study compares two group interventions for emotional support: a 'Meaning-Centered Group' designed to help find purpose post-treatment, and a 'Discussion Group' for general survivor support. The effectiveness of conducting these groups virtually is also being tested.See study design

What are the potential side effects?

Since the interventions involve psychological support rather than medication, traditional side effects aren't expected. Participants may experience emotional discomfort when discussing personal experiences related to their cancer journey.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I had breast cancer before, but it did not spread to other parts of my body.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

feasibility as measured by the proportion of patients enrolled who complete 4 out of 8 modules, which should not be not lower than 40%.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Meaning-Centered Group for Breast Cancer Survivors (MCG-BCS)Experimental Treatment1 Intervention

Group II: Discussion Group (DG)Active Control1 Intervention

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor

1,933 Previous Clinical Trials

585,516 Total Patients Enrolled

203 Trials studying Breast Cancer

81,137 Patients Enrolled for Breast Cancer

American Cancer Society, Inc.OTHER

224 Previous Clinical Trials

110,351 Total Patients Enrolled

33 Trials studying Breast Cancer

8,884 Patients Enrolled for Breast Cancer

Wendy Lichtenthal, PhDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center

7 Previous Clinical Trials

1,174 Total Patients Enrolled

1 Trials studying Breast Cancer

267 Patients Enrolled for Breast Cancer

Media Library

Manualized Group Intervention Clinical Trial Eligibility Overview. Trial Name: NCT01775085 — N/A

Breast Cancer Research Study Groups: Meaning-Centered Group for Breast Cancer Survivors (MCG-BCS), Discussion Group (DG)

Breast Cancer Clinical Trial 2023: Manualized Group Intervention Highlights & Side Effects. Trial Name: NCT01775085 — N/A

Manualized Group Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT01775085 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being accepted for the trial?

"The information posted on clinicaltrials.gov confirms that this trial has ceased to recruit patients since February 1st, 2022. Initially listed on January 1st 2013, the study is no longer accepting applicants but there are still 2291 other medical studies actively seeking participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Group Interventions for Breast Cancer Survivors

2013. "Group Interventions for Breast Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01775085.